Variation in endometrial thickening in women with amenorrhea on tamoxifen.
- 1 March 1998
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 48 (1) , 81-85
- https://doi.org/10.1023/a:1005999008736
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tamoxifen Therapy and Carcinogenic RiskJNCI Journal of the National Cancer Institute, 1995
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- Pathology of endometrium treated with tamoxifen.Journal of Clinical Pathology, 1994
- Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogenCarcinogenesis: Integrative Cancer Research, 1994
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- Tamoxifen and endometrial lesionsThe Lancet, 1993
- Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cellsCarcinogenesis: Integrative Cancer Research, 1992
- Endometrial lesions in patients undergoing tamoxifen therapyInternational Journal of Gynecology & Obstetrics, 1991
- Hysteroscopic follow-up during Tamoxifen treatmentEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
- Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case reportBJOG: An International Journal of Obstetrics and Gynaecology, 1990